Results
1 -
10 of
22Novel toxins and Parkinsonu2019s disease: N-methylation and oxidation as metabolic bioactivation of neurotoxin, Amine Oxidases: Function and Dysfunction Biosynthesis of N-Methylisoquinolinium Ion, a Potent Inhibitor of Catecholamine Metabolism, from 1,2,3,4-Tetrahydroisoquinoline Through N-Methyl-1,2,3,4-Tetrahydroisoquinoline in Human Brain, Basic, Clinical, and Therapeutic Aspects of Alzheimer?s and Parkinson?s Diseases Effects of single and repeated administration of 1,2,3,4-tetrahydroisoquinoline analogs on the binding of [11C]raclopride to dopamine D2 receptors in the mouse brain, Journal of Neural Transmission Metabolic Bioactivation of Endogenous Isoquinolines as Dopaminergic Neurotoxins to Elicit Parkinson?s Disease, Alzheimer?s and Parkinson?s Diseases Effect of Chronic Administration of 1,2,3,4-Tetrahydroisoquinoline and Its Derivatives on the Monkey: Immunohistochemical Study, Alzheimer?s and Parkinson?s Diseases The interaction of tetrahydroisoquinoline derivatives with antinociceptive action of morphine and oxotremorine in mice, Journal of Neural Transmission Detection of Tetrahydroisoquinoline, a Parkinsonism-Related Compound, in Parkinsonian Brains and Foods by Gas Chromatography-Mass Spectrometry, Basic, Clinical, and Therapeutic Aspects of Alzheimer?s and Parkinson?s Diseases Inhibitory Effects of Endogenous Tetrahydroisoquinolines on Mitochondrial Respiration in Mouse Brain, Alzheimer?s and Parkinson?s Diseases Synthesis of the first representative of the 2,3,6,7-tetrahydro-1H-benzo[d]azonine system from 1-cyanomethyl-2-methyl-1,2,3,4-tetrahydroiso-quinolinium chloride and dimethyl acetylene-dicarboxylate, Chemistry of Heterocyclic Compounds